Literature DB >> 23435225

Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices.

Marie-Claude Robert1, Valérie Pomerleau, Mona Harissi-Dagher.   

Abstract

BACKGROUND/AIMS: To compare the complications leading to best-corrected visual acuity (BCVA) loss in patients with Boston keratoprosthesis type 1 (KPro) and glaucoma drainage device (GDD) and those with KPro alone.
METHODS: Retrospective case series of all patients who underwent KPro surgery at the Centre Hospitalier de l'Université de Montréal between 2008 and 2011. Preoperative diagnoses, BCVA and complications were tabulated and analysed.
RESULTS: KPro surgery was performed in 96 eyes: 18 eyes (19%) had KPro and GDD while 78 eyes (81%) had KPro only. Median BCVA at postoperative 6 months was 20/150 in both groups. Seven eyes (39%) with KPro and GDD experienced vision loss due to complications such as glaucoma progression (three eyes, 22%), tube occlusion (four eyes, 22%) and choroidal haemorrhage (three eyes, 17%). Vitreous incarceration was the most common cause of tube occlusion. Vitreoretinal, glaucoma and infectious complications caused BCVA loss in 16 eyes (21%) with KPro alone (p=0.13).
CONCLUSIONS: Glaucoma progression is a major cause of visual decline post-KPro. However, GDD implantation should only be performed in carefully selected patients. Because of a high risk of vitreous incarceration within the tube, a complete pars plana vitrectomy should be performed prior to GDD implantation.

Entities:  

Mesh:

Year:  2013        PMID: 23435225     DOI: 10.1136/bjophthalmol-2012-302770

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

Review 1.  Aqueous shunts for glaucoma.

Authors:  Victoria L Tseng; Anne L Coleman; Melinda Y Chang; Joseph Caprioli
Journal:  Cochrane Database Syst Rev       Date:  2017-07-28

2.  Innovative approaches to glaucoma management of Boston keratoprosthesis type 1.

Authors:  Thasarat S Vajaranant; Jessica Liu; Jacob Wilensky; M Soledad Cortina; Ahmad A Aref
Journal:  Curr Ophthalmol Rep       Date:  2016-07-26

Review 3.  The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis.

Authors:  Steven Bonneau; C Maya Tong; Yelin Yang; Mona Harissi-Dagher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-04-06       Impact factor: 3.535

4.  Transscleral Cyclophotocoagulation for the Treatment of Uncontrolled Glaucoma in a Boston Keratoprosthesis Type II Patient.

Authors:  Ana Orive Bañuelos; Begoña Arana Larrea; Alja Crnej; Ana Arce Soto; Noelia Andollo Victoriano; Jaime Etxebarria Ecenarro
Journal:  Case Rep Ophthalmol       Date:  2022-03-17

5.  COMPARISON OF VISUAL AND ANATOMICAL OUTCOMES OF EYES UNDERGOING TYPE I BOSTON KERATOPROSTHESIS WITH COMBINATION PARS PLANA VITRECTOMY WITH EYES WITHOUT COMBINATION VITRECTOMY.

Authors:  Jennifer I Lim; Lindsay Machen; Andrea Arteaga; Faris I Karas; Robert Hyde; Dingcai Cao; Marcia Niec; Thasarat S Vajaranant; M Soledad Cortina
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

Review 6.  Glaucoma management after corneal transplantation surgeries.

Authors:  Helen L Kornmann; Steven J Gedde
Journal:  Curr Opin Ophthalmol       Date:  2016-03       Impact factor: 3.761

7.  Three-Dimensional Optical Coherence Tomography Imaging For Glaucoma Associated With Boston Keratoprosthesis Type I and II.

Authors:  Ziad Khoueir; Firas Jassim; Boy Braaf; Linda Yi-Chieh Poon; Edem Tsikata; James Chodosh; Claes H Dohlman; Benjamin J Vakoc; Brett E Bouma; Johannes F de Boer; Teresa C Chen
Journal:  J Glaucoma       Date:  2019-08       Impact factor: 2.503

8.  Ultra-wide field imaging to assess the optic nerve and retina in Boston type I and II keratoprosthesis patients.

Authors:  William R Bloom; Matthew D Karl; Sarah B Smith; Yusra F Shao; William Terrell; Ahmad B Tarabishy; Andrew J Hendershot; Rebecca A Kuennen; Tyler D Oostra; Thomas F Mauger; Colleen M Cebulla
Journal:  Eye Vis (Lond)       Date:  2022-05-07

9.  Vision retention in early versus delayed glaucoma surgical intervention in patients with Boston Keratoprosthesis type 1.

Authors:  Mark Lin; Anand Bhatt; Asghar Haider; Grace Kim; Marjan Farid; Mason Schmutz; Sameh Mosaed
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.